Results 71 to 80 of about 144 (102)

A snapshot of the microbiome of blood and ticks of captive cheetahs (<i>Acinonyx jubatus</i>) from selected conservation facilities in South Africa. [PDF]

Front Microbiol
Masenya K, Ledwaba MB, Khumalo N, Makgabo SM, Mokgokong SP, Chaisi M.   +5 more
europepmc   +1 more source

SARS-CoV-2 Helicase (NSP13) Interacts with Mammalian Polyamine and HSP Partners in Promoting Viral Replication. [PDF]

Curr Issues Mol Biol
Sitobo Z, Navhaya LT, Nqumla N, Masenya M, Molapo M, Mthembu Y, Godlo S, Makhoba XH.   +7 more
europepmc   +1 more source

First Report of Zearalenone Production by <i>Talaromyces</i> Isolated from <i>Bidens pilosa</i> Using LC-q-TOF-MS and Molecular Networking. [PDF]

Mycobiology
Maphari PW, Nemaridili N, Khwathisi A, Traore AN, Moyo B, Masenya K, Madala NE.   +6 more
europepmc   +1 more source

Semen characteristics of indigenous Lusitu boars compared to the Large White pig genotype reared in Zambia. [PDF]

Open Vet J
Abigaba R, Mwaanga ES, Sianangama PC, Nyanga PH, Mwenya WNM.   +4 more
europepmc   +1 more source

<i>Inxeba Elinga Phakathi:</i> The Danger of Mental Health Invisibility and the Role of Social Community Caregiving. [PDF]

Int J Environ Res Public Health
Penxa-Matholeni N.
europepmc   +1 more source

BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> Infection. [PDF]

N Engl J Med
Schmidt AC, Fairlie L, Hellström E, Luabeya Kany Kany A, Middelkoop K, Naidoo K, Nair G, Gela A, Nemes E, Scriba TJ, Cinar A, Frahm N, Mogg R, Kaufman D, Dunne MW, Hatherill M, BCG REVAX Study Team.   +16 more
europepmc   +1 more source

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. [PDF]

AIDS, 2021
MacBrayne CE, Rutstein RM, Wiznia AA, Graham B, Alvero CG, Fairlie L, Lypen K, George KH, Townley E, Moye J, Costello DG, Reding CA, Barroso Hofer C, Crauwels HM, Woot de Trixhe X, Tambuyzer L, Vanveggel S, Opsomer M, Kiser JJ, and the IMPAACT P1090 Protocol Team.   +19 more
europepmc   +1 more source

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens. [PDF]

Open Forum Infect Dis
Sokhela S, Venter WDF, Bosch B, Woods J, McCann K, Akpomiemie G, Chandiwana N, Mashabane N, Tembo A, Simmons B, Lalla-Edward S, Siedner MJ, Sinxadi P, Hermans L, Fairlie L, Vos A, Abrams E, Manne-Goehler JM, Moorhouse M, Clayden P, Norris S, Qavi A, Chersich M, Masenya M, Arulappan N, Hill A.   +25 more
europepmc   +1 more source

Grain Products: Traditional and Innovative Technologies. [PDF]

Foods
Gómez M, Pereira E.
europepmc   +1 more source

Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. [PDF]

AIDS, 2019
Meyers T, Samson P, Acosta EP, Moye J, Townley E, Bradford S, Marillo L, Denson K, Hovind L, Sise T, Teppler H, Mathiba SR, Masenya M, Hesseling A, Cotton MF, Krogstad P, IMPAACT P1101 Team.   +16 more
europepmc   +1 more source